Microsoft's Market Paradox: Robust Earnings Clash With Investor Skepticism

Microsoft shares are down 14% YTD despite strong Q2 FY26 results. Investors question AI profitability as the company invests billions in health tech and data centers.

Microsoft's operational performance continues to impress, yet its stock is facing a surprising downturn. The shares have shed approximately 14% since the start of the year, trading well below the all-time high of $539.83 reached in late October 2025. This creates a tangible paradox: the company's strong quarterly results are being met with deep-seated investor doubt regarding its artificial intelligence strategy.

A Closer Look at the Financial Performance

For the second quarter of its 2026 fiscal year, Microsoft reported adjusted earnings per share of $4.14. This figure surpassed analyst expectations by 6.7% and represented a 24% increase compared to the same period last year. Revenue climbed to $81.3 billion, marking 17% growth. A particularly striking highlight was the 230% surge in commercial bookings, which significantly exceeded forecasts. The commercial remaining performance obligation now stands at over $600 billion, an indicator of the deep commitment businesses worldwide have to Microsoft's services.

Concurrently, the company returned $12.7 billion to shareholders in Q2 through dividends and share repurchases, a 32% year-over-year increase. The next quarterly dividend of $0.91 per share is scheduled for payment on June 11, 2026.

The Roots of Investor Caution

The stock's underperformance relative to the broader market is notable. While the wider market sits only about 3% below its peak, Microsoft shares are down roughly 25% from their high, marking the weakest start to a year since the 2008 financial crisis. This pressure stems from mounting questions about when, and to what extent, the company's massive AI investments will translate into tangible profits. The software sector as a whole is under scrutiny, with investors concerned that AI could disrupt traditional enterprise software models in the medium term.

Strategic Bets on Health and Infrastructure

Amid this backdrop, Microsoft is advancing on two significant fronts. On the product side, it has launched Copilot Health, a new platform that consolidates health records, wearable device data, and medical histories within a secure Copilot environment. Chief Product Officer Aparna Chennapragada has characterized 2026 as the year AI evolves from a tool into a genuine partner.

In parallel, the company is in negotiations to lease several hundred megawatts of data center capacity in Abilene, Texas. This location is on a campus previously abandoned by Oracle and forms part of the Stargate project, one of the largest AI infrastructure initiatives in the United States. The capacity could support the expansion of Azure or directly benefit OpenAI, in which Microsoft holds a major stake. Fully developing the site is projected to cost tens of billions of dollars.

All eyes are now on Microsoft's upcoming quarterly report, due on April 28, 2026. With Copilot Health in the market, the Texas project in development, and a record backlog, this announcement will be a critical test of whether the monetization of AI is accelerating at the pace the investment community demands.